Correction of anemia: do we follow clinical guidelines?

Abstract

It is an observational study of 228 patients with cancer and chemotherapy-induced anaemia (CIA). 192 patients received chemotherapy, 16 patients - hormone therapy, 20 patients - target therapy. In 118 patients with CIA were considered as iron deficiency. 49.1 % of patients with therapy was prescribed by an oncologist, 50.9 % of the therapy was administered by physician of other specialties. 51.7 % of patients received oral iron for the correction of CIA, 42.6 % patients did not receive any therapy of CIA. In 43.2 % of patients, at least one cycle of chemotherapy was postponed due to CIA. The appointment of the 67 patients monotherapy ferric carboxymaltose 500-1000 mg once a week, has allowed 14 days to increase the level of hemoglobin 16.2 [4.0-19.1] g/L.